{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:40:47Z","timestamp":1788871247988,"version":"build-2803163510"},"reference-count":59,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Science Center","award":["NN 401534040"],"award-info":[{"award-number":["NN 401534040"]}]},{"name":"Medical University of Warsaw","award":["1MA\/2010-13"],"award-info":[{"award-number":["1MA\/2010-13"]}]}],"content-domain":{"domain":["neuropeptidesjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropeptides"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.npep.2014.07.004","type":"journal-article","created":{"date-parts":[[2014,8,6]],"date-time":"2014-08-06T20:01:54Z","timestamp":1407355314000},"page":"257-266","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Altered expression of V1a receptors mRNA in the brain and kidney after myocardial infarction and chronic stress"],"prefix":"10.1016","volume":"48","author":[{"given":"E.","family":"Milik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Szczepanska-Sadowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Dobruch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Cudnoch-Jedrzejewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Maslinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.npep.2014.07.004_b0005","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0079-6123(08)00403-2","article-title":"The parvocellular vasopressinergic system and responsiveness of the hypothalamic pituitary adrenal axis during chronic stress","volume":"170","author":"Aguilera","year":"2008","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.npep.2014.07.004_b0010","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1124\/jpet.108.137745","article-title":"Effects of novel vasopressin receptor antagonists on renal function and cardiac hypertrophy in rats with experimental congestive heart failure","volume":"326","author":"Bishara","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.npep.2014.07.004_b0015","doi-asserted-by":"crossref","first-page":"R979","DOI":"10.1152\/ajpregu.00520.2001","article-title":"Cytokine-mediated downregulation of vasopressin V1a receptors during acute endotoxemia in rats","volume":"282","author":"Bucher","year":"2002","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.npep.2014.07.004_b0020","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.regpep.2004.02.001","article-title":"Differential regulation of central vasopressin receptors in transgenic rats with low brain angiotensinogen","volume":"119","author":"Campos","year":"2004","journal-title":"Regul. Pept."},{"key":"10.1016\/j.npep.2014.07.004_b0025","doi-asserted-by":"crossref","first-page":"F351","DOI":"10.1152\/ajprenal.00049.2006","article-title":"Axial heterogeneity of vasopressin-receptor subtypes along the human and mouse collecting duct","volume":"292","author":"Carmosino","year":"2007","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.npep.2014.07.004_b0030","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0014-2999(03)01285-8","article-title":"Neuroendocrine pharmacology of stress","volume":"463","author":"Carrasco","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.npep.2014.07.004_b0035","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0022-2828(03)00053-1","article-title":"The role of arginine vasopressin and its receptors in the normal and failing rat heart","volume":"35","author":"Chandrashekhar","year":"2003","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.npep.2014.07.004_b0040","doi-asserted-by":"crossref","first-page":"H751","DOI":"10.1152\/ajpheart.1994.267.2.H751","article-title":"Chronic intravenous administration of V1 vasopressin agonist results in sustained hypertension","volume":"267","author":"Cowley","year":"1994","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.npep.2014.07.004_b0045","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.regpep.2007.01.010","article-title":"Interaction of AT1 receptors and V1a receptors-mediated effects in the central cardiovascular control during the post-infarct state","volume":"142","author":"Cudnoch-Jedrzejewska","year":"2007","journal-title":"Regul. Pept."},{"key":"10.1016\/j.npep.2014.07.004_b0050","doi-asserted-by":"crossref","first-page":"R672","DOI":"10.1152\/ajpregu.00543.2009","article-title":"Brain vasopressin V1 receptors contribute to enhanced cardiovascular responses to acute stress in chronically stressed rats and rats with myocardial infarction","volume":"298","author":"Cudnoch-J\u0119drzejewska","year":"2010","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.npep.2014.07.004_b0055","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1152\/physrev.1994.74.2.323","article-title":"Functional organization of central pathways regulating the cardiovascular system","volume":"74","author":"Dampney","year":"1994","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.npep.2014.07.004_b0060","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.amjhyper.2005.09.024","article-title":"Tempol in the dorsomedial hypothalamus attenuates the hypertensive response to stress in rabbits","volume":"19","author":"De Matteo","year":"2006","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.npep.2014.07.004_b0065","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/10253890500456287","article-title":"Enhanced involvement of brain vasopressin V1 receptors in cardiovascular responses to stress in rats with myocardial infarction","volume":"8","author":"Dobruch","year":"2005","journal-title":"Stress"},{"key":"10.1016\/j.npep.2014.07.004_b0070","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1161\/01.CIR.82.5.1724","article-title":"Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD)","volume":"82","author":"Francis","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.npep.2014.07.004_b0075","doi-asserted-by":"crossref","first-page":"H2264","DOI":"10.1152\/ajpheart.01072.2003","article-title":"Acute myocardial infarction induces hypothalamic cytokine synthesis","volume":"286","author":"Francis","year":"2004","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.npep.2014.07.004_b0080","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ejphar.2007.11.063","article-title":"The vasopressin system \u2013 from antidiuresis to psychopathology","volume":"583","author":"Frank","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.npep.2014.07.004_b0085","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1161\/CIRCULATIONAHA.109.851675","article-title":"Elevated depression symptoms predict long-term cardiovascular mortality in patients with atrial fibrillation and heart failure","volume":"120","author":"Frasure-Smith","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.npep.2014.07.004_b0090","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1002\/hbm.21315","article-title":"Brain systems for baroreflex suppression during stress in humans","volume":"33","author":"Gianaros","year":"2012","journal-title":"Hum. Brain Mapp."},{"issue":"Suppl. 3","key":"10.1016\/j.npep.2014.07.004_b0095","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.3949\/ccjm.73.Suppl_3.S19","article-title":"The role of vasopressin in congestive heart failure","volume":"73","author":"Goldsmith","year":"2006","journal-title":"Cleve. Clin. J. Med."},{"key":"10.1016\/j.npep.2014.07.004_b0100","first-page":"349","article-title":"Vasopressin V1a, V1b and V2 receptors mRNA in the kidney and heart of the renin transgenic TGR(mRen2)27 and Sprague Dawley rats","volume":"53","author":"G\u00f3\u017ad\u017a","year":"2002","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.npep.2014.07.004_b0105","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0361-9230(02)00943-7","article-title":"Differential expression of vasopressin V1a and V1b receptors mRNA in the brain of renin-transgenic TGR(mRen2)27 and Sprague Dawley rats","volume":"59","author":"G\u00f3\u017ad\u017a","year":"2003","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.npep.2014.07.004_b0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10253890802046281","article-title":"Stress, depression and cardiovascular dysregulation: a review of neurobiological mechanisms and the integration of research from preclinical disease models","volume":"12","author":"Grippo","year":"2009","journal-title":"Stress"},{"key":"10.1016\/j.npep.2014.07.004_b0115","doi-asserted-by":"crossref","first-page":"R1333","DOI":"10.1152\/ajpregu.00614.2001","article-title":"Cardiovascular alterations and autonomic imbalance in an experimental model of depression","volume":"282","author":"Grippo","year":"2002","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.npep.2014.07.004_b0120","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1440-1681.1997.tb01791.x","article-title":"Interactions between vasopressin and baroreflex control of the sympathetic nervous system","volume":"24","author":"Hasser","year":"1997","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.npep.2014.07.004_b0125","doi-asserted-by":"crossref","first-page":"5149","DOI":"10.1113\/jphysiol.2009.179739","article-title":"Vasomotor and respiratory responses evoked from the dorsolateral periaqueductal grey are mediated by the dorsomedial hypothalamus","volume":"587","author":"Horiuchi","year":"2009","journal-title":"J. Physiol."},{"key":"10.1016\/j.npep.2014.07.004_b0130","doi-asserted-by":"crossref","first-page":"R130","DOI":"10.1152\/ajpregu.00574.2009","article-title":"Dorsomedial hypothalamus mediates autonomic, neuroendocrine, and locomotor responses evoked from the medial preoptic area","volume":"298","author":"Hunt","year":"2010","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.npep.2014.07.004_b0135","doi-asserted-by":"crossref","first-page":"218","DOI":"10.2174\/1570159X11311020008","article-title":"Vasopressin and oxytocin in control of the cardiovascular system","volume":"11","author":"Japund\u017ei\u0107-\u017eigon","year":"2013","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.npep.2014.07.004_b0140","doi-asserted-by":"crossref","first-page":"H227","DOI":"10.1152\/ajpheart.01157.2007","article-title":"Inhibition of brain proinflammatory cytokine synthesis reduces hypothalamic excitation in rats with ischemia-induced heart failure","volume":"295","author":"Kang","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.npep.2014.07.004_b0145","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1113\/jphysiol.2009.184580","article-title":"Increased vasopressin transmission from the paraventricular nucleus to the rostral medulla augments cardiorespiratory outflow in chronic intermittent hypoxia-conditioned rats","volume":"588","author":"Kc","year":"2010","journal-title":"J. Physiol."},{"key":"10.1016\/j.npep.2014.07.004_b0150","doi-asserted-by":"crossref","first-page":"H1786","DOI":"10.1152\/ajpheart.1999.277.5.H1786","article-title":"Brain \u201couabain\u201d and angiotensin II contribute to cardiac dysfunction after myocardial infarction","volume":"277","author":"Leenen","year":"1999","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.npep.2014.07.004_b0155","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1038\/sj.npp.1301036","article-title":"Antidepressant-like effects of the corticotropin-releasing factor 1 receptor antagonist, SSR125543, and the vasopressin 1b receptor antagonist, SSR149415, in a DRL-72 s schedule in the rat","volume":"31","author":"Louis","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.npep.2014.07.004_b0160","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.neulet.2011.05.049","article-title":"Down-regulation of V1a receptors in the cerebellum after myocardial infarction","volume":"499","author":"Milik","year":"2011","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.npep.2014.07.004_b0165","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0895-7061(98)00177-0","article-title":"Central vasopressin is modulated by chronic blockade of the renin\u2013angiotensin system in experimental left ventricular hypertrophy","volume":"12","author":"Muders","year":"1999","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.npep.2014.07.004_b0170","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0079-6123(02)39023-X","article-title":"The central vasopressinergic system in experimental left ventricle hypertrophy and dysfunction","volume":"139","author":"Muders","year":"2002","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.npep.2014.07.004_b0175","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0006-8993(93)91224-G","article-title":"Central cardiovascular effects of AVP and AVP analogs with V1, V2 and \u2018V3\u2019 agonistic or antagonistic properties in conscious dog","volume":"610","author":"Noszczyk","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.npep.2014.07.004_b0180","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ejphar.2006.11.063","article-title":"Vasopressin V1a receptor enhances baroreflex via the central component of the reflex arc","volume":"558","author":"Oikawa","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.npep.2014.07.004_b0185","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1210\/endo.131.1.1535312","article-title":"Distribution of V1a and V2 vasopressin receptor messenger ribonucleic acids in rat liver, kidney, pituitary and brain","volume":"131","author":"Ostrowski","year":"1992","journal-title":"Endocrinology"},{"key":"10.1016\/j.npep.2014.07.004_b0190","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1210\/endo.135.4.7925112","article-title":"Cellular localization of vasopressin V1a receptor messenger ribonucleic acid in adult male rat brain, pineal, and brain vasculature","volume":"135","author":"Ostrowski","year":"1994","journal-title":"Endocrinology"},{"key":"10.1016\/j.npep.2014.07.004_b0195","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1210\/edrv.22.4.0436","article-title":"Stressor specificity of central neuroendocrine responses: implications for stress-related disorders","author":"Pac\u00e1k","year":"2001","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.npep.2014.07.004_b0200","doi-asserted-by":"crossref","first-page":"R243","DOI":"10.1152\/ajpregu.1997.273.1.R243","article-title":"Localization of the vasopressin V1a and V2 receptors within the renal cortical and medullary circulation","volume":"273","author":"Park","year":"1997","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.npep.2014.07.004_b0205","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.amjcard.2008.12.020","article-title":"Clinical characteristics and four-year outcomes of patients in the Rhode Island Takotsubo Cardiomyopathy Registry","volume":"103","author":"Regnante","year":"2009","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.npep.2014.07.004_b0210","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00213-006-0424-1","article-title":"Differential roles of amygdaloid nuclei in the anxiolytic- and antidepressant-like effects of the V1b receptor antagonist, SSR149415, in rats","volume":"187","author":"Salome","year":"2006","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.npep.2014.07.004_b0215","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000167005","article-title":"Role of vasopressin and vasopressin receptor antagonists in type I cardiorenal syndrome","volume":"27","author":"Schrier","year":"2009","journal-title":"Blood Purif."},{"key":"10.1016\/j.npep.2014.07.004_b0220","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1177\/000331976001100505","article-title":"Simple techniques for the surgical occlusion of coronary vessels in the rat","volume":"11","author":"Selye","year":"1960","journal-title":"Angiology"},{"key":"10.1016\/j.npep.2014.07.004_b0225","doi-asserted-by":"crossref","first-page":"H689","DOI":"10.1152\/ajpheart.1990.259.3.H689","article-title":"Autonomic pathophysiology in heart failure: carotid baroreceptor-cardiac reflexes","volume":"259","author":"Sopher","year":"1990","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.npep.2014.07.004_b0230","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.neuropharm.2007.12.013","article-title":"Blockade of central vasopressin receptors reduces the cardiovascular response to acute stress in freely moving rats","volume":"54","author":"Stojici\u0107","year":"2008","journal-title":"Neuropharmacology"},{"issue":"Suppl. 8","key":"10.1016\/j.npep.2014.07.004_b0235","first-page":"61","article-title":"Role of neuropeptides in central control of cardiovascular responses to stress","volume":"59","author":"Szczepanska-Sadowska","year":"2008","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.npep.2014.07.004_b0240","doi-asserted-by":"crossref","first-page":"R1217","DOI":"10.1152\/ajpregu.1994.267.5.R1217","article-title":"Prolonged stimulation of intrarenal V1 vasopressin receptors in sustained hypertension","volume":"267","author":"Szczepanska-Sadowska","year":"1994","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.npep.2014.07.004_b0245","first-page":"509","article-title":"Brain and cardiovascular diseases: common neurogenic background of cardiovascular, metabolic and inflammatory diseases","volume":"61","author":"Szczepanska-Sadowska","year":"2010","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.npep.2014.07.004_b0250","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.vph.2007.02.001","article-title":"Effect of YM218, a nonpeptide vasopressin V(1A) receptor-selective antagonist, on rat mesangial cell hyperplasia and hypertrophy","volume":"46","author":"Tahara","year":"2007","journal-title":"Vascul. Pharmacol."},{"key":"10.1016\/j.npep.2014.07.004_b0255","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1172\/JCI200419656","article-title":"The vasopressin V1b receptor critically regulates hypothalamic\u2013pituitary\u2013adrenal axis activity under both stress and resting conditions","volume":"113","author":"Tanoue","year":"2004","journal-title":"J. Clin. Invest."},{"issue":"Suppl. A","key":"10.1016\/j.npep.2014.07.004_b0260","doi-asserted-by":"crossref","first-page":"56A","DOI":"10.1016\/0735-1097(93)90464-C","article-title":"Abnormalities of baroreflex control in heart failure","volume":"22","author":"Thames","year":"1993","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.npep.2014.07.004_b0265","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.npep.2005.08.001","article-title":"Blockade of angiotensin II AT1 receptors inhibits pressor action of centrally administered interleukin-1beta in Sprague Dawley rats","volume":"39","author":"Ufnal","year":"2005","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2014.07.004_b0270","doi-asserted-by":"crossref","first-page":"5015","DOI":"10.1210\/endo.139.12.6382","article-title":"Comparative distribution of vasopressin V1b and oxytocin receptor messenger ribonucleic acids in brain","volume":"139","author":"Vaccari","year":"1998","journal-title":"Endocrinology"},{"key":"10.1016\/j.npep.2014.07.004_b0275","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1196\/annals.1296.035","article-title":"Regulation of vasopressin V1b receptors and stress adaptation","volume":"1018","author":"Volpi","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.npep.2014.07.004_b0280","doi-asserted-by":"crossref","first-page":"H1700","DOI":"10.1152\/ajpheart.00722.2011","article-title":"Enhanced activation of RVLM-projecting PVN neurons in rats with chronic heart failure","volume":"302","author":"Xu","year":"2012","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.npep.2014.07.004_b0285","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.peptides.2010.10.014","article-title":"Arginine vasopressin in hypothalamic paraventricular nucleus is transferred to the caudate nucleus to participate in pain modulation","volume":"32","author":"Yang","year":"2011","journal-title":"Peptides"},{"key":"10.1016\/j.npep.2014.07.004_b0290","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.neuroscience.2008.07.049","article-title":"The single-prolonged stress paradigm alters both the morphology and stress response of magnocellular vasopressin neurons","volume":"156","author":"Yoshii","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.npep.2014.07.004_b0295","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1161\/01.HYP.0000246614.47231.25","article-title":"Novel mechanisms of sympathetic regulation in chronic heart failure","volume":"48","author":"Zucker","year":"2006","journal-title":"Hypertension"}],"container-title":["Neuropeptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143417914000687?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143417914000687?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T23:56:58Z","timestamp":1589241418000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143417914000687"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":59,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0143417914000687"],"URL":"https:\/\/doi.org\/10.1016\/j.npep.2014.07.004","relation":{},"ISSN":["0143-4179"],"issn-type":[{"value":"0143-4179","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Altered expression of V1a receptors mRNA in the brain and kidney after myocardial infarction and chronic stress","name":"articletitle","label":"Article Title"},{"value":"Neuropeptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.npep.2014.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}